Merck-Rolling Submission-License Application for MK-3475

Posted By
1/13/2014 10:56am
View other posts by
Activity
Replies: 3

http://www.fiercebiotech.com/press-releases/merck-initiates-rolling-subm...

Merck Initiates Rolling Submission of U.S. Biologics License Application for MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma

Expects to Complete Application in First Half of 2014
January 13, 2014 08:30 AM Eastern Standard Time

Read more: Merck Initiates Rolling Submission of U.S. Biologics License Application for MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma - FierceBiotech http://www.fiercebiotech.com/press-releases/merck-initiates-rolling-submission-us-biologics-license-application-mk-3475#ixzz2qIJiIsJ6
Subscribe at FierceBiotech

I'm me, not a statistic. Praying to not be one for years yet.

Jerry, thanks for posting.  The market certainly likes the news: "Shares of Merck & Co rose as much as 6 percent on Monday after the company filed the first part of an application to market its experimental drug, MK-3475, for advanced melanoma."

Although not crystal clear, the wording of the article you posted suggests that the initial approval may be for those who have tried ipi first.

To me, this also puts pressure on BMS to get nivo approved in 2014.

Thank you for posting this article. Great article and great news!

Tina

 I wish he would come sooner!